FDA Approves Blood Test for Alzheimer's Amyloid Assessment

Roche's Elecsys pTau217 blood test has received FDA approval to assess amyloid-beta accumulation in the brain, aiding early Alzheimer's diagnosis using simple blood draws instead of expensive PET scans or invasive procedures.

This Wire brief sits within Fusion42's coverage of Medtech.